P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

Sandborn William; D. Haens Geert; Wolf Doug; Hanauer Stephen; Jovanovic Igor; Ghosh Subrata; Petersen AnnKatrin; Hua Steven; Lee Ji Hwan; Charles Lorna; Usiskin Keith; Danese Silvio; Feagan Brian

doi:10.14309/01.ajg.0000722896.32651.d6

P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

Sandborn William, D. Haens Geert, Wolf Doug, Hanauer Stephen, Jovanovic Igor, Ghosh Subrata, Petersen AnnKatrin, Hua Steven, Lee Ji Hwan, Charles Lorna, Usiskin Keith, Danese Silvio, Feagan Brian

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	English
Journal	American journal of gastroenterology
Volume	115
DOIs	https://doi.org/10.14309/01.ajg.0000722896.32651.d6
Publication status	Published - 1 Dec 2020
Externally published	Yes

Access to Document

10.14309/01.ajg.0000722896.32651.d6

Cite this

William, S., Geert, D. H., Doug, W., Stephen, H., Igor, J., Subrata, G., AnnKatrin, P., Steven, H., Hwan, L. J., Lorna, C., Keith, U., Silvio, D., & Brian, F. (2020). P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study. American journal of gastroenterology, 115. https://doi.org/10.14309/01.ajg.0000722896.32651.d6

@article{930c94bb91b94f71811f0b5eb1096c41,

title = "P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study",

author = "Sandborn William and Geert, {D. Haens} and Wolf Doug and Hanauer Stephen and Jovanovic Igor and Ghosh Subrata and Petersen AnnKatrin and Hua Steven and Hwan, {Lee Ji} and Charles Lorna and Usiskin Keith and Danese Silvio and Feagan Brian",

year = "2020",

month = dec,

day = "1",

doi = "10.14309/01.ajg.0000722896.32651.d6",

language = "English",

volume = "115",

journal = "American journal of gastroenterology",

issn = "0002-9270",

publisher = "Springer Nature",

}

William, S, Geert, DH, Doug, W, Stephen, H, Igor, J, Subrata, G, AnnKatrin, P, Steven, H, Hwan, LJ, Lorna, C, Keith, U, Silvio, D & Brian, F 2020, 'P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study', American journal of gastroenterology, vol. 115. https://doi.org/10.14309/01.ajg.0000722896.32651.d6

TY - JOUR

T1 - P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

AU - William, Sandborn

AU - Geert, D. Haens

AU - Doug, Wolf

AU - Stephen, Hanauer

AU - Igor, Jovanovic

AU - Subrata, Ghosh

AU - AnnKatrin, Petersen

AU - Steven, Hua

AU - Hwan, Lee Ji

AU - Lorna, Charles

AU - Keith, Usiskin

AU - Silvio, Danese

AU - Brian, Feagan

PY - 2020/12/1

Y1 - 2020/12/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101439283&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/33566499

U2 - 10.14309/01.ajg.0000722896.32651.d6

DO - 10.14309/01.ajg.0000722896.32651.d6

M3 - Article

C2 - 33566499

SN - 0002-9270

VL - 115

JO - American journal of gastroenterology

JF - American journal of gastroenterology

ER -

P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

Access to Document

Other files and links

Cite this